Abstract:Background and Purpose— Moyamoya disease (MMD) is a rare cerebral vasculopathy characterized by bilateral internal carotid artery stenosis and often leads to stroke in children or young adults. Although familial inheritance is well recognized, the genetic basis of MMD remains poorly understood. Methods— A 2-stage genome-wide association study was conducted involving 1492 cases and 5084 controls. In the discovery stage, logistic regression was used to test associations, and imputation was conducted based on genotyped single-nucleotide polymorphisms (SNPs). In the validation stage, the top significant SNPs were again genotyped in an independent cohort. Fixed-effects inverse variance-weighted meta-analysis was used in the combined discovery and validation samples. Furthermore, association analysis was conducted in subgroups using patient clinical data. Results— The study identified 10 novel risk loci with genome-wide significance (P<5×10−8) and confirmed a previously reported locus on 17q25. No significant SNP showed evidence of heterogeneity between the 2 stages. Cumulatively, these SNPs explained 14.76% of disease risk variance—a substantial proportion of the 39.02% of risk variance explained by all genome-wide genotyped SNPs. One SNP, rs9916351 in RNF213 (Pcombined=4.57×10−54; odds ratio, 1.96), showed a stronger genetic effect on early-onset than late-onset MMD (P=0.003). Two novel SNPs in genes regulating homocysteine metabolism, rs9651118 in MTHFR (Pcombined=2.49×10−19; odds ratio, 0.65) and rs117353193 in TCN2 (Pcombined=6.15×10−13; odds ratio, 1.43), were associated with high-serum homocysteine in MMD cases. Additionally, another SNP associated with MMD (rs2107595 in HDAC9; Pcombined=1.49×10−29; odds ratio, 1.64) was previously implicated in large-vessel disease. Tissue enrichment analysis showed that the genes of associated loci were highly expressed in the immune system (false discovery rate, <0.05). Conclusions— This study identifies several novel susceptibility genes for MMD. The association with homocysteine metabolism and the immune system enrichment of susceptibility gene expression suggest that therapeutic interventions targeting these pathways may be effective approaches for MMD treatment.

Insights into the regulatory role of epigenetics in moyamoya disease: Current advances and future prospectives

Genome-Wide DNA Methylation Profiling Reveals Low Methylation Variability in Moyamoya Disease

The Genetic Basis of Moyamoya Disease

The Progression of Pathophysiology of Moyamoya Disease

Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment

Advances in the Genetics of Moyamoya Disease

Abstract TP284: Transcriptome Profiling of Peripheral Blood Mononuclear Cells in Moyamoya Disease

Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study

Molecular Biomarkers Affecting Moyamoya Disease

Identification of lysosome-related hub genes as potential biomarkers and immune infiltrations of moyamoya disease by multiple bioinformatics methods and machine-learning strategies

Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing

RNF213 in moyamoya disease: Genotype–phenotype association and the underlying mechanism

Identification of diagnostic markers for moyamoya disease by combining bulk RNA-sequencing analysis and machine learning

Bioinformatics analysis reveals the landscape of immune cell infiltration and novel immune-related biomarkers in moyamoya disease

Modifiable Risk Factors Associated With Moyamoya Disease

Abstract P749: Functional and Molecular Characterization of Endothelial and Vascular Smooth Muscle Cells Derived From Moyamoya Disease-Induced Pluripotent Stem Cells

Research progress of moyamoya disease combined with renovascular hypertension

Identification of oxidative phosphorylation-related genes in moyamoya disease by combining bulk RNA-sequencing analysis and machine learning

Adult Moyamoya Disease and Moyamoya Syndrome: What Is New?

In-depth cerebrovascular lipidomics profiling for discovering novel biomarkers and mechanisms in moyamoya and intracranial atherosclerotic disease

Comprehensive Analysis and In Vitro Verification of Endothelial-Mesenchymal Transition-Related Genes in Moyamoya Disease